CIRSE's flagship journal

CardioVascular and Interventional Radiology (CVIR) is an official journal of

the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Founded in 1978 by Professors Herbert L. Abrams and Eberhard Zeitler,

CVIR is the longest-running journal in the field of vascular and interventional radiology.

 

 

CIRSE Members have unlimited online access to all CVIR articles. To access the full text articles, log in with the credentials for myCIRSE.

 


news

Call for applications

Prof. Klaus Hausegger's and Prof. Jim Reekers' terms of office as CVIR and CVIR Endovascular Editor-in-Chief, respectively, will come to an end in 2025. Therefore, CIRSE has launched a call for applications to fill these positions, as well as the position of editor-in-chief of its soon to be launched journal CVIR Oncology (planned to start accepting submissions in 2025). Each of the three positions is for a four-year term beginning in 2025.

 

Find out more here and make sure to submit your application by March 4!

 

CIRSE SOP on Management of Endoleaks Following Endovascular Aneurysm Repair

Endoleaks represent the most common complication after EVAR. Some types are associated with ongoing risk of aneurysm rupture and necessitate long-term surveillance and secondary interventions, and this SOP provides up-to-date recommendations for its safe performance.

 

 

Read the article here!

 

Visual abstracts

Optimize your article with the new feature in CVIR! Submit a visual abstract of your paper in addition to the textual abstract, to highlight your research and findings. All article types are eligible, with the exception of editorials, letters to the editor and commentaries. Click here to download the template. 

 

More information here!

 


New impact factor

We are happy to announce CVIR’s 2022 impact factor which increased to 2.9! This achievement underscores the exceptional quality and importance of the articles published in the journal. A big thank you to the journal’s dedicated authors, reviewers, editors, and readers for their invaluable contributions and support. 

 

Read the latest articles here!

Mastering MSK interventions

CVIR’s November issue features a special section on MSK interventions curated by world-renown expert in the field: Julien Garnon.

This special section presents the latest technical advancements and most significant data from the literature on hot topics in MSK. The goal is to give any IR an overview of what is feasible and for which result.

  

Read the articles here!

 

Editor's Choice: February 2024

The benefit of the ‘halo’: Read the outcomes of the long-term results of this single centre prospective study on 130 patients that underwent treatment with paclitaxel eluting stents for SFA lesions 27 of which developed a focal reaction expressed with a ‘halo’ sign on US around the stent. The overall outcomes of the study were satisfactory, and the enhanced reaction appears to be significantly corelated with increased primary patency but without increased complications. 

 

Read the article here!

 


Guidelines for reporting on studies

Are you about to submit your paper to CVIR?

 

Click here to find out which biological/biomedical reporting checklists are mandatory when submitting to CVIR.

 

Direct transfer of good papers from CVIR to CVIR Endovascular!

CIRSE has a journal family!

 

Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be offered transfer to CVIR Endovascular for consideration.


Journal metrics

 

2-year impact factor

 2.9
 

5-year impact factor

 2.6
 

Downloads in 2022

591,937
  Days to first decision (2022 median)

 

5 days    


the CIRSE journal family